We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$106B
AUM Growth
+$2.27B
Cap. Flow
-$488M
Cap. Flow %
-0.46%
Top 10 Hldgs %
30.07%
Holding
4,478
New
179
Increased
2,056
Reduced
1,848
Closed
61

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$101M
2
GEV icon
GE Vernova
GEV
+$75.4M
3
CRH icon
CRH
CRH
+$48.5M
4
CRWD icon
CrowdStrike
CRWD
+$45.8M
5
DELL icon
Dell
DELL
+$35.8M

Sector Composition

Rank Sector Weight
1 Technology 30.98%
2 Financials 12.55%
3 Healthcare 11.48%
4 Consumer Discretionary 10.52%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DZSI
3526
DELISTED
DZS Inc. Common Stock
DZSI
$14.2K ﹤0.01%
12,121
-20,215
-63% -$27.5K
CVEO icon
3527
Civeo
CVEO
$315M
$14.2K ﹤0.01%
568
AGRO icon
3528
Adecoagro
AGRO
$1.37B
$14K ﹤0.01%
1,441
+720
+100% +$7.46K
SOGP
3529
Sound Group
SOGP
$52.3M
$13.9K ﹤0.01%
6,723
NEXN
3530
Nexxen International
NEXN
$608M
$13.9K ﹤0.01%
2,475
RLYB icon
3531
Rallybio
RLYB
$85.4M
$13.9K ﹤0.01%
1,297
-3,697
-74% -$50.1K
WHWK
3532
Whitehawk Therapeutics
WHWK
$235M
$13.8K ﹤0.01%
9,487
-15,899
-63% -$29.5K
SSYS icon
3533
Stratasys
SSYS
$771M
$13.5K ﹤0.01%
1,607
+799
+99% +$7.59K
KLRS
3534
Kalaris Therapeutics
KLRS
$98.3M
$13.4K ﹤0.01%
804
-2,196
-73% -$38.8K
MAXN
3535
DELISTED
Maxeon Solar Technologies
MAXN
$13.4K ﹤0.01%
157
-251
-62% -$53.2K
ALTO icon
3536
Alto Ingredients
ALTO
$348M
$13.3K ﹤0.01%
9,187
+4,431
+93% +$7.66K
ASRT
3537
DELISTED
Assertio
ASRT
$13.3K ﹤0.01%
713
-7,238
-91% -$108K
XTLB
3538
XTL Biopharmaceuticals
XTLB
$6.88M
$13.2K ﹤0.01%
+1,396
New +$14.3K
LX
3539
LexinFintech Holdings
LX
$236M
$13.1K ﹤0.01%
7,943
-119
-1% -$211
BHIL
3540
DELISTED
Benson Hill, Inc.
BHIL
$13.1K ﹤0.01%
2,461
-4,906
-67% -$32.5K
HOLI
3541
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$13K ﹤0.01%
600
ZKH
3542
ZKH Group
ZKH
$449M
$13K ﹤0.01%
3,325
GNLX icon
3543
Genelux
GNLX
$118M
$12.9K ﹤0.01%
6,624
-17,375
-72% -$59K
CARM
3544
DELISTED
Carisma Therapeutics
CARM
$12.7K ﹤0.01%
8,387
-26,701
-76% -$39.8K
TRVG
3545
trivago
TRVG
$396M
$12.7K ﹤0.01%
6,318
IVAC
3546
DELISTED
Intevac Inc
IVAC
$12.6K ﹤0.01%
3,270
-25,909
-89% -$102K
AHG
3547
Akso Health Group
AHG
$1.16B
$12.3K ﹤0.01%
14,347
VRNA
3548
DELISTED
Verona Pharma
VRNA
$12.2K ﹤0.01%
841
+343
+69% +$5.01K
ARCO icon
3549
Arcos Dorados Holdings
ARCO
$1.73B
$12.2K ﹤0.01%
1,350
+727
+117% +$7.48K
IMCR icon
3550
Immunocore
IMCR
$1.7B
$12K ﹤0.01%
355
+171
+93% +$8.72K

Similar funds

RhumbLine Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, RhumbLine Advisers held 4,478 positions worth $106B, up 2.2% from $104B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

RhumbLine Advisers's Q2 2024 filing shows 179 new, 2,056 increased, 1,848 reduced and 61 closed positions. Its largest new stake was GE Vernova: 475,685 shares worth $81.6M. The largest sale was iShares Russell 1000 ETF, an estimated $180M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q2 2024 buy was GE Vernova: 475,685 shares worth $81.6M.
  • RhumbLine Advisers added most to ExxonMobil in Q2 2024, an estimated $101M increase.
  • RhumbLine Advisers's biggest Q2 2024 reduction was iShares Russell 1000 ETF, cutting an estimated $180M.
  • RhumbLine Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $121M.
  • RhumbLine Advisers's ten largest holdings make up 30% of its $106B portfolio in Q2 2024.
  • RhumbLine Advisers opened 179 new positions and closed 61 in Q2 2024.
  • RhumbLine Advisers's portfolio value rose 2.2% quarter-over-quarter to $106B.

Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.